Leptin In Malign Pleural Efusions: May Be A New Marker?

Serap Duru

TR EN

Leptin In Malign Pleural Efusions: May Be A New Marker?

Abstract

Objective: The pleural effusions may be caused by malignant or benign diseases. In this study, it was aimed to determine the serum and pleural leptin levels in non-malignant and malignant pleural effusions. Methods: Patients with non-malignant (n=20) and malignant pleural effusions (n=20), and healthy control group (n=20) were included in this cross-sectional study. The age and body mass index (BMI) were comparative between study groups. The serum leptin levels in all subjects and pleural effusions leptin level in patients with pleural effusion were determined. Leptin levels were compared in terms of study groups and gender of subjects. Results: The leptin levels in serum and pleural effusions in group with malignant pleural effusion were significantly higher than both the non-malignant effusion and control groups (p<0.001). While there was no statistically significant difference between male and female patients in terms of pleural effusions leptin levels (p=0.097), serum leptin level of the female patients was significantly higher than the male patients (p<0.001). Conclusion: Increased serum and pleural effusions leptin levels in malignant pleural effusions shows that leptin is a useful new marker.

Keywords

Leptin, malignancy, pleural effusion

References

1. Gürkök S, Genç O. Malignant pleural effusion. Turkiye Klinikleri J Surg Med Sci 2006; 2: 37-41.
2. Light RW. Pleural effusion. N Eng J Med 2002; 346: 1971-7.
3. Yokoyama A, Maruyama M, Ito K. Interluekin 6 activity in pleural effusion. Chest 1992; 102: 1055-9.
4. Kiropoulus TS, Kostikos K, Oikonomidi S. Acute phase markers for the differeantiation of infectious and malignant pleural effusions. Respir Med 2007; 101: 910-8.
5. Bunatova K, Obermajer N, Kotyza J, at al. Levels of cathepsine S and H in pleural fluids of inflammatory and neoplastic origin. Int J Biol Markers 2009; 24:47-21.
6. Iwagava K, Numata Y, Katsuura G. Structurefunction studies of human leptin. J Biol- Chem, 1998; 273: 35245-9.
7. Gong DW, Bi S, Pratley RE, Weintraub BD, at al. Genomic structure and promoter analysis of the human obese gene. J BiolChem 1996; 271: 3971-4.
8. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the Mouse obese gene and its human homologue. Nature 1994: 372: 425-32.
9. Pelleymounter MA, Cullen MJ, Baker MB, at al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-3.
10. Kamohara S, Burcelin R, Halaas JL., et al Acute stimülation of glucose metabolism in mice by leptin treatments. Nature 1997; 389 : 374-7.

11. Ergün A. Adipose tissue and the adipocyte: review. Turkiye Klinikleri J Med Sci 2005; 25: 412-20.
12. Ergün A. Leptin. Turkiye Klinikleri J Med Sci 1999; 19: 130-6.
13. Emral R. Adiponectin and other cytokines: medical education. Turkiye Klinikleri J Med Sci 2006; 26: 409-20.
14. Magni P, Vettor Pagano C, Calcagno A, et al. Expression of a leptin receptor in immortalised gonadotropin-releasing hormone secreting neurons. Endocrinology 1999; 140: 1581-5.
15. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996; 12: 318-20.
16. Bennet BD, Solar GP, Yuan JO, et al. A role for leptin and its cognate receptor in haematopoiesis.Curr Biol 1996; 6: 1170-80 . 17. Lord GM, Matarese G, Howard JK, et al. Leptin modulaters the T cell immune response and reverses starvation induced immunosuppression. Nature 1998; 394: 897- 901.
18. Bouloumie A, Dresler HCA, Lafontan M. Leptin, the product of the Ob gene promotes angiogenesis. Circ Res 1998; 83: 1059-66.
19. Bado A, Levasseur S, Le Marchand-Brustel Y, et al. The Stomach is a source of leptin. Nature 1998; 394: 790-3.
20. Iwaniec UT, Heaney RP, Cullen DM, et al. Leptin increases the number of mineralized bone nodules in vitro. J Bone Miner Res 1998; 13: 2-12.
21. Hoggard N, Hunter L, Duncan JS, et al. Leptin and leptin receptor mRNA and protein expression in the murine fetus and plecenta. Proc Natl Acad Sci USA 1997; 94: 11073-8.
22. Briscoe CP, Hanif S, Arch CR, et al. Leptin receptor long form signalling in a human liver cell line. Cytokine 2001; 14: 225-9.
23. Ciof JA, Shaffer AW, Zupancic TJ. Novel B219/OB receptor isoforms: possible role of leptin in hematopoesis and repruduction. Not Med 1996; 2: 585-9.
24. Glassow A, Haidan A, Hilbers U, et al. Expression of Ob receptor in normal human adrenals: differantial regulation of adrenocortical and adrenomeddullary function by leptin. J Clin Endocrinol Metab 1998; 83: 4459-66.
25. Ishikawa M, Kitayama J, Nagawa H. Expression pattern of leptin and leptin receptor (ob-r) in human gastric cancer. World J Gastroenterol 2006; 12: 5517-22.
26. Caldefie-Chezet F. Leptin: a proliferative factor of breast cancer? Study on human ductal carcinoma. Biochemical and biophysical research comminications. Biochem Biophys Res Commun 2005; 334: 737-41.
27. Terzidis A. Elevated serum leptin levels: a risk factor for non small cell lung cancer? Oncology 2009; 76: 19-25.
28. Riberio R. A functional polymorphysm in the promoter region of leptin gene increases susceptibility for non small cell lung cancer. Eur J Cancer 2006; 42: 1188-93.
29.Çelik G, Kaya A, Poyraz B. Diagnostic value of leptin in tuberculous pleural effusions. Int J Clin Pract 2006; 60: 1437-42.
30. Prabha C, Supriya P, Das SD, et al. Leptin response in patients with tuberculous pleuritis. Indian J Med Res 2008; 128: 721-7.
31. McConway MG, Johnson D, Kelly A, et al. Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adult humans. Ann Clin Biochem 2000; 37: 717-23.

Details

Primary Language

English

Subjects

Chest Diseases

Journal Section

Systematic Reviews and Meta Analysis

Authors

Serap Duru ^*
Türkiye

Publication Date

June 3, 2012

Submission Date

December 19, 2010

Acceptance Date

October 18, 2011

Published in Issue

Year 2011 Volume: 8 Number: 4

IZ

https://izlik.org/JA38WG85HG

APA

Duru, S. (2012). Leptin In Malign Pleural Efusions: May Be A New Marker? Ankara Üniversitesi Tıp Fakültesi Mecmuası, 8(4), 127-131. https://izlik.org/JA38WG85HG

AMA

1.Duru S. Leptin In Malign Pleural Efusions: May Be A New Marker? Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2012;8(4):127-131. https://izlik.org/JA38WG85HG

Chicago

Duru, Serap. 2012. “Leptin In Malign Pleural Efusions: May Be A New Marker?”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 8 (4): 127-31. https://izlik.org/JA38WG85HG.

EndNote

Duru S (June 1, 2012) Leptin In Malign Pleural Efusions: May Be A New Marker? Ankara Üniversitesi Tıp Fakültesi Mecmuası 8 4 127–131.

IEEE

[1]S. Duru, “Leptin In Malign Pleural Efusions: May Be A New Marker?”, Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 8, no. 4, pp. 127–131, June 2012, [Online]. Available: https://izlik.org/JA38WG85HG

ISNAD

Duru, Serap. “Leptin In Malign Pleural Efusions: May Be A New Marker?”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 8/4 (June 1, 2012): 127-131. https://izlik.org/JA38WG85HG.

JAMA

1.Duru S. Leptin In Malign Pleural Efusions: May Be A New Marker? Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2012;8:127–131.

MLA

Duru, Serap. “Leptin In Malign Pleural Efusions: May Be A New Marker?”. Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 8, no. 4, June 2012, pp. 127-31, https://izlik.org/JA38WG85HG.

Vancouver

1.Serap Duru. Leptin In Malign Pleural Efusions: May Be A New Marker? Ankara Üniversitesi Tıp Fakültesi Mecmuası [Internet]. 2012 Jun. 1;8(4):127-31. Available from: https://izlik.org/JA38WG85HG

Leptin In Malign Pleural Efusions: May Be A New Marker?

Malign Plevral Efüzyonlarda Leptin: Yeni Bir Markır Olabilir mi?

Abstract

Keywords

Leptin In Malign Pleural Efusions: May Be A New Marker?

Abstract

Keywords

References

Details

Primary Language

Subjects

Journal Section

Authors

Publication Date

Submission Date

Acceptance Date

Published in Issue

IZ

Cite